Cargando…

Optimal Upfront Treatment in Surgically Resectable Pancreatic Cancer Candidates: A High-Volume Center Retrospective Analysis

Pancreatic adenocarcinoma is a devastating disease with only 15–20% of patients resectable at diagnosis. Neoadjuvant chemotherapy for this cohort is becoming increasingly popular; however, there are no published randomized trials that support the use of neoadjuvant chemotherapy over upfront surgery...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maloney, Sarah, Itchins, Malinda, Arena, Jennifer, Sahni, Sumit, Howell, Viive M., Hayes, Sarah A., Gill, Anthony J., Clarke, Stephen J., Samra, Jaswinder, Mittal, Anubhav, Pavlakis, Nick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235361/ https://www.ncbi.nlm.nih.gov/pubmed/34207372 http://dx.doi.org/10.3390/jcm10122700

Ejemplares similares

The Right Treatment Strategy for the Right Patient: A Biomarker-Driven Approach to Neoadjuvant vs. Surgery-First Management of Resectable and Borderline Resectable Pancreatic Cancer
por: Nahm, Christopher B., et al.
Publicado: (2022)

The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Lymphocyte-to-Monocyte Ratio (LMR) as Biomarkers in Resected Pancreatic Cancer
por: Maloney, Sarah, et al.
Publicado: (2023)

Identification of Novel Biomarkers in Pancreatic Tumor Tissue to Predict Response to Neoadjuvant Chemotherapy
por: Sahni, Sumit, et al.
Publicado: (2020)

The role of diagnostic, prognostic, and predictive biomarkers in the management of early pancreatic cancer
por: Maloney, Sarah, et al.
Publicado: (2023)

Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy
por: Sahni, Sumit, et al.
Publicado: (2023)

Small Molecule KRAS Inhibitors: The Future for Targeted Pancreatic Cancer Therapy?
por: Gillson, Josef, et al.
Publicado: (2020)

The quantum leap in therapeutics for advanced ALK+ non-small cell lung cancer and pursuit to cure with precision medicine
por: Itchins, Malinda, et al.
Publicado: (2022)

Drain fluid biomarkers for prediction and diagnosis of clinically relevant postoperative pancreatic fistula: A narrative review
por: Rykina-Tameeva, Nadya, et al.
Publicado: (2022)

Corrigendum: Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas
por: Mehta, Shreya, et al.
Publicado: (2021)

Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas
por: Mehta, Shreya, et al.
Publicado: (2021)

Autophagy: A Key Player in Pancreatic Cancer Progression and a Potential Drug Target
por: Gillson, Josef, et al.
Publicado: (2022)

Breakthrough 5-year survival with pembrolizumab in Keynote-001 study: horizon shifting in advanced non-small cell lung cancer with immune check point inhibition
por: de Silva, Madhawa, et al.
Publicado: (2020)

Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single‐cell analysis
por: Byeon, Sooin, et al.
Publicado: (2023)

Somatostatin Receptor SSTR-2a Expression Is a Stronger Predictor for Survival Than Ki-67 in Pancreatic Neuroendocrine Tumors
por: Mehta, Shreya, et al.
Publicado: (2015)

The role of staging laparoscopy in pancreatic adenocarcinoma and its effect on patients’ survival
por: Jambor, Maxwell A., et al.
Publicado: (2022)

Drain fluid biomarkers for the diagnosis of clinically relevant postoperative pancreatic fistula: a diagnostic accuracy systematic review and meta-analysis
por: Rykina-Tameeva, Nadya, et al.
Publicado: (2023)

Life-threatening diarrhea in neuroendocrine tumors: two case reports
por: Gordon, Emma, et al.
Publicado: (2021)

Do you get the GIST? Successful resection of a giant 3.5 kg gastrointestinal stromal tumour
por: Borruso, Luca, et al.
Publicado: (2022)

Safety and Efficacy of Pancreaticoduodenectomy in Octogenarians
por: Huang, Yeqian, et al.
Publicado: (2021)

Surgical management of high-grade pancreatic injuries: Insights from a high-volume pancreaticobiliary specialty unit
por: Chui, Juanita Noeline, et al.
Publicado: (2023)

Anti-PD-1 Monoclonal Antibodies (mAbs) Are Superior to Anti-PD-L1 mAbs When Combined with Chemotherapy in First-Line Treatment for Metastatic Non-Small Cell Lung Cancer (mNSCLC): A Network Meta-Analysis
por: Wei, Joe Q., et al.
Publicado: (2023)

Systematic Review and Meta-Analysis on the Role of Chemotherapy in Advanced and Metastatic Neuroendocrine Tumor (NET)
por: Wong, Matthew H., et al.
Publicado: (2016)

Postoperative pancreatic fistula: a review of traditional and emerging concepts
por: Nahm, Christopher B, et al.
Publicado: (2018)

Circulating and disseminated tumor cells in pancreatic cancer and their role in patient prognosis: a systematic review and meta-analysis
por: Stephenson, David, et al.
Publicado: (2017)

Establishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesothelioma
por: Hudson, Amanda L., et al.
Publicado: (2014)

Granular cell tumour of the pancreas: a case report and systematic review
por: Tree, Kevin, et al.
Publicado: (2023)

Patient-derived xenograft models of colorectal cancer in pre-clinical research: a systematic review
por: Brown, Kai M., et al.
Publicado: (2016)

Dramatic response to selective internal radiation therapy for unresectable hepatocellular carcinoma
por: Park, Woo Daniel, et al.
Publicado: (2015)

Synchronous Operable Pancreatic and Breast Cancer Without Genetic Mutation: A Literature Review and Discussion
por: Ofri, Adam, et al.
Publicado: (2022)

Diagnostic Accuracy of Imaging Modalities in the Evaluation of Vascular Invasion in Pancreatic Adenocarcinoma: A Meta-Analysis
por: Li, Angela E., et al.
Publicado: (2013)

Brain Metastases in Lung Cancers with Emerging Targetable Fusion Drivers
por: Tan, Aaron C., et al.
Publicado: (2020)

Optimal approach for upfront resectable non-small-cell lung cancer
por: van Meerbeeck, Jan P.
Publicado: (2013)

Anatomy of the neural fibers at the superior mesenteric artery—a cadaver study
por: Reinehr, Michael D., et al.
Publicado: (2022)

Multivisceral resection of pancreatic neuroendocrine tumours: a report of two cases
por: Gundara, Justin S, et al.
Publicado: (2011)

Efficacy of upfront hepatectomy without neoadjuvant chemotherapy for resectable colorectal liver metastasis
por: Ono, Kosuke, et al.
Publicado: (2021)

Meta‐analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer
por: Versteijne, E., et al.
Publicado: (2018)

Neoadjuvant chemotherapy for borderline resectable and upfront resectable pancreatic cancer increasing overall survival and disease-free survival?
por: Fossaert, Violette, et al.
Publicado: (2022)

Clinical Outcomes of Upfront Primary Tumor Resection in Synchronous Unresectable Metastatic Colorectal Cancer
por: Shin, Ji Eun, et al.
Publicado: (2023)

Prognostic Impact of Tumor-Infiltrating Lymphocytes and Neutrophils on Survival of Patients with Upfront Resection of Pancreatic Cancer
por: Miksch, Rainer C., et al.
Publicado: (2019)

The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer
por: Chan, Joseph C. Y., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2bbl47tt68p3ouf82kehk1c0d3